Profile for Stemline Therapeutics Inc. (STML)

$ 11.83 0.00 (0.00%) Volume: 0 4:00 PM EDT Jun 10, 2020
Business Description:
Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.
Address: 750 Lexington Avenue, 11th Floor, New York, NY, US, 10022
Telephone: +1 646 502-2311 Website: http://www.stemline.com
Facsimile: +1 646 389-0968 Email: [email protected]
Details
CEO: Ivan Bergstein
Employees: 104 Market Cap: 621.2m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1264587
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Biological Products, Except Diagnostic Substances (2836)